Democrats Meet With Trump to Discuss Drug Pricing
Representatives Elijah Cummings, D-Maryland, and Peter Welch, D-Vermont, met with President Donald Trump yesterday to form an unlikely alliance against the high cost of prescription drugs. The legislators presented a bill that would allow Medicare to negotiate prices, an idea that Trump had supported during his campaign. According to Kaiser Health News, Cummings commended the president as “aware of the problem” and “enthusiastic” in remarks after the meeting.
Replacement Bill Isn’t Called “Trumpcare,” White House Insists
The inevitable nickname of “Trumpcare” for the Republican bill to replace Obamacare has been greeted with resistance by the Trump administration, Politico reports. Democrats have seized on the term, but officials want the bill to be branded by its official name, the American Health Care Act, as they don’t want it associated with the negative connotations of Obamacare among conservatives. HHS secretary Tom Price offered up a slightly catchier alternative: “I prefer to call it PatientCare,” he said at a White House press briefing.
FDA Public Meeting Attempts to Define “Healthy” Foods
A battle that started over the word “healthy” on KIND bar labels has spurred the FDA to hold a public meeting in hopes of determining what actually makes a food healthy, reported STAT. Today’s meeting will unite nutritionists, food company representatives, and others to discuss topics like consumers’ perceptions of healthy foods and whether health claims should be based on nutrient content.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More